articleTop 1% cited
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Nature Medicine · 2004 · Vol. 10(9) · pp. 942–949
Tyler J. Curiel✉(Tulane University)George Coukos(University of Pennsylvania)Linhua Zou(Tulane University)Xavier Álvarez(Tulane University)Pui Cheng(Tulane University)Peter Mottram(Tulane University)Melina Evdemon-Hogan(Tulane University)José R. Conejo-García(University of Pennsylvania)Lin Zhang(University of Pennsylvania)Matthew E. Burow(Tulane University)Yun Zhu(Tulane University)Shuang Wei(Tulane University)Ilona Kryczek(Tulane University)Ben Daniel(Tulane University)Alan N. Gordon(Baylor University Medical Center)Leann Myers(Tulane University)Andrew A. Lackner(Tulane University)Mary L. Disis(University of Washington)Keith L. Knutson(University of Washington)Lieping Chen(Johns Hopkins University)Weiping Zou(Tulane University)
Immune Cell Function and InteractionT-cell and B-cell ImmunologyImmunotherapy and Immune ResponsesFOXP3IL-2 receptorBiologyImmune privilegeImmune systemCancer researchOvarian cancerImmunologyT cellCancer
MeSH terms
AnimalsAscitesCell MovementDendritic CellsDNA-Binding ProteinsFemaleHumansImmunity, CellularLymphocyte ActivationOvarian NeoplasmsT-LymphocytesReceptors, Interleukin-2CD4-Positive T-LymphocytesImmunophenotypingMicroscopy, Confocal
Citations
5,022
FWCI
67.52
field-weighted impact
References
49
Percentile
100%
vs. same field & year
Citations per year
Cited by
Immunosuppressive Strategies that are Mediated by Tumor Cells
Annual Review of Immunology · 2006 · 1,705 citations
<scp>LAG</scp>3 (<scp>CD</scp>223) as a cancer immunotherapy target
Immunological Reviews · 2017 · 946 citations
Targeting Treg cells in cancer immunotherapy
European Journal of Immunology · 2019 · 481 citations
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Cancers · 2014 · 1,562 citations
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Journal of Leukocyte Biology · 2009 · 1,423 citations
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Science Translational Medicine · 2016 · 2,413 citations
Natural Innate and Adaptive Immunity to Cancer
Annual Review of Immunology · 2011 · 2,024 citations
Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant Lesions
Clinical Cancer Research · 2006 · 819 citations
References
CD4+CD25+ suppressor T cells: more questions than answers
Nature reviews. Immunology · 2002 · 2,106 citations
CD4+CD25high Regulatory Cells in Human Peripheral Blood
The Journal of Immunology · 2001 · 1,845 citations
Control of Regulatory T Cell Development by the Transcription Factor <i>Foxp3</i>
Science · 2003 · 8,062 citations
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Nature Immunology · 2003 · 2,816 citations
Immunologic tolerance maintained by CD25<sup>+</sup> CD4<sup>+</sup> regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance
Immunological Reviews · 2001 · 1,512 citations
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Nature Immunology · 2003 · 7,605 citations
Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity
The Journal of Immunology · 1999 · 1,473 citations
Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma
The Journal of Immunology · 2002 · 1,461 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.